Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 4 (2008), Issue 8 (August)

1. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
   AIDS Res Hum Retroviruses, 24(7): 911-7. [Abstract] [Full-text]
2. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.
   BMC Infect Dis, 8: 93. [Abstract] [Full-text]
3. Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis c patients receiving peginterferon Alpha-2b plus ribavirin.
   Aliment Pharmacol Ther. [Abstract] [Full-text]
4. Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
   Eur J Gastroenterol Hepatol, 20(7): 680-7. [Abstract] [Full-text]
5. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.
   Gastroenterology, 135(2): 451-8. [Abstract] [Full-text]
6. HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.
   J Antimicrob Chemother, 62(3): 451-5. [Abstract] [Full-text]
7. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
   Gynecol Oncol, 110(3): S18-25. [Abstract] [Full-text]
8. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.
   Antimicrob Agents Chemother, 52(9): 3144-60. [Abstract] [Full-text]
9. Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.
   J Acquir Immune Defic Syndr, 49(1): 40-7. [Abstract] [Full-text]
10. HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso.
    J Acquir Immune Defic Syndr, 49(1): 17-25. [Abstract] [Full-text]
11. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy.
    AIDS Res Hum Retroviruses, 24(8): 1031-5. [Abstract] [Full-text]
12. Immune suppression leading to hepatitis C virus re-emergence after sustained virological response.
    J Med Virol, 80(10): 1720-2. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.